PMDA drug package insert
マーキュリーアイ
PMDA OTC drug · 株式会社わかさ生活 · package insert May 24, 2024
Key facts
| Brand names | マーキュリーアイ |
|---|---|
| Companies | 製造販売元／テイカ製薬株式会社,販売会社／株式会社わかさ生活 |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | 液剤 |
| OTC effect category | 人工涙液 |
| Package insert date | May 24, 2024 |
| PMDA document key | 470004_K2404000012 |
| PMDA company code | 470004 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: